medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2010, Number 3

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2010; 8 (3)

Severe Favre-Racouchot disease: A case report

Enríquez MJ, Domínguez GMA, Llergo VRJ, Siu MCM, Alfaro OLP
Full text How to cite this article

Language: Spanish
References: 12
Page: 192-195
PDF size: 896.87 Kb.


Key words:

severe Favre-Racouchot disease, solar exposition, cyst, comedons.

ABSTRACT

The Favre-Racouchot disease is due to solar exposure that causes skin degeneration, multiple comedons and yellow-colored follicular cysts, usually located in the periorbitary region in elderly individuals. Factors commonly associated to this pathology are smoking and low temperature exposition —as well as chemical substances. Pathogenesis of the disease remains uncertain; theories have focused on the elastic fibers degeneration of the dermis, allowing the presence of comedons.
Treatment is mainly based on topic retinoids , dermoabrassion, manual comedons extraction and in severe cases, surgical removal of the lesions.
We report a case of a 63 year-old male with severe Favre-Racouchot disease successfully treated with surgery and a favorable outcome in his quality of life.


REFERENCES

  1. Kulkarni V. “Favre-Racouchot síndrome”. Indian J Dermatol Venereol Leprol 1991; 57: 244-245.

  2. Patterson WM, Fox MD, Schwartz RA, “Favre-Racouchot disease”. Review. International Journal of Dermatology 2004; 43, 167-169.

  3. Sánchez-Yus E, Del Río E, Simón P, Requena L, Vázquez H. “The histopathology of closed and open comedones of Favre-Racouchot Disease”. Arch Dermatol 1997; 133: 743-745.

  4. Hedelund L, Wulf HC. “Favre-Racouchot disease provoked by UV-A1 and UV-B exposure”. Arch Dermatol 2004, 140 (1): 129-131.

  5. Cuce LC, Paschoal LHC, Curban GV. “Cutaneos nodular elastoidosis with cysts and comedones”. Arch Dermatol 1964; 89: 798-802.

  6. Skoulakis C, Manios A, Chimona T, Tsiftsis D. “Surgical management of Favre-Racouchot syndrome”. Can J Plast Surg 2001; 9 (3): 91-93.

  7. Sharkey MJ, Keller RA, McCollough ML. “Favre-Racouchot Syndrome; a combined therapeutic approach”. Arch Dermatol 1992; 128: 615-616.

  8. Breit S, Flaig MJ, Wolff H, Plewig G. “Favre-Racouchot like disease after radiation therapy”. J Am Acad Dermatol 2003, 49 (1): 117-118.

  9. Helm F. “Nodular cutaneos eastosis with cysts and comedones (Favre- Racouchot syndrome). Report of a case”. Arch Dermatol. 1961; 84: 182- 184.

  10. Lever FW. Histopatología de la Piel. 7a ed, Buenos Aires, Intermédica, 1990, 287.

  11. Mohs FE, McCall MW, Greenway HT. “Curettage for removal of the comedones and cysts of the Favre-Racouchot syndrome”. Arch Dermatol 1982; 118: 365-366.

  12. Rallis E, Karanikola E, Verros C. “Succesful Treatment of Favre-Racouchot Disease with 0.05% tazaroteno gel”. Arch Dermatol 2007; 143: 810-812.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2010;8